- Intravitreal Anti-vascular Endothelial Growth Factor versus Observation in Acute Central Serous Chorioretinopathy: One-year Results
-
Park SU, Lee SJ, Kim M
- KMID: 2344222
- Korean J Ophthalmol.
- 2014 Aug;28(4):306-313.
PURPOSE: To evaluate the efficacy of anti-vascular endothelial growth factor (VEGF) compared with observation for treating acute central serous chorioretinopathy (CSC). METHODS: A retrospective study of 36 patients with acute CSC,... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Anti-vascular Endothelial Growth Factor for Typical Exudative Age-related Macular Degeneration in Eyes with Good Baseline Visual Acuity
-
Chang YS, Han JI, Yoo SJ, Lew YJ, Kim JH
- KMID: 2345823
- Korean J Ophthalmol.
- 2014 Dec;28(6):466-472.
- doi: 10.3341/kjo.2014.28.6.466
PURPOSE: To investigate 12-month treatment outcomes of anti-vascular endothelial growth factor therapy in eyes with typical exudative age-related macular degeneration with good baseline visual acuity. METHODS: This retrospective observational case series... -
- CITED
-
- Close
- SHARE
-
- Close
- Intravitreal Anti-vascular Endothelial Growth Factor for Newly Diagnosed Symptomatic Polypoidal Choroidal Vasculopathy with Extrafoveal Polyps
-
Kim JH, Lee DW, Choi SC, Kim JW, Lee TG, Kim CG, Cho HJ
- KMID: 2363848
- Korean J Ophthalmol.
- 2015 Dec;29(6):404-410.
- doi: 10.3341/kjo.2015.29.6.404
PURPOSE: To evaluate the 12-month outcome of anti-vascular endothelial growth factor (VEGF) treatment for extrafoveal polypoidal choroidal vasculopathy (PCV). METHODS: This retrospective observational study included 32 eyes of 32 patients newly... -
- CITED
-
- Close
- SHARE
-
- Close
